However, reductions in total and SGRQ sub-domain scores did not reach statistical significance for AZD3199 800 μg and formoterol 9 μg, in comparison with placebo.
← all excerpts
Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind study.
1
—
—